Hepatobiliary Hepatcellular Carcinoma October 26, 2025 Posted by myadmin 17 Sep A phase III, open-label, randomized study of atezolizumab with lenvatinib or sorafenib versus lenvatinib or sorafenib alone in HCC pr...Continue reading
